InsidersTradesSigma
Total declarations
Companies
▲ Purchases (16 ops.)
▼ Sales (6 ops.)
Insider track record
OtherDisclosed buys
16
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Stephenson Brian C, Autre. Officer active across 2 companies, notably BridgeBio Pharma, Inc.. Cumulatively, 40 filings have been published. Split: 16 buys · 6 sells. Total volume traded: €3.4m. History available since 5 January 2023. The latest transaction was filed on 25 February 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Stephenson Brian C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
2,891 sharesCommon StockSEC:0001780030-26-000005:0
Canonical exit: 22 Sept 2026 (T+90)
3,000 sharesCommon StockSEC:0001780030-26-000005:1
Canonical exit: 22 Sept 2026 (T+90)
3,400 sharesCommon StockSEC:0001780030-26-000005:2
Canonical exit: 22 Sept 2026 (T+90)
100 sharesCommon StockSEC:0001780030-26-000005:3
Canonical exit: 22 Sept 2026 (T+90)
580 sharesCommon StockSEC:0001780030-26-000005:4
Canonical exit: 24 Sept 2026 (T+90)
4,212 sharesCommon StockSEC:0001780030-26-000005:5
Canonical exit: 24 Sept 2026 (T+90)
1,358 sharesCommon StockSEC:0001780030-26-000005:6
Canonical exit: 24 Sept 2026 (T+90)
100 sharesCommon StockSEC:0001780030-26-000005:7
Canonical exit: 24 Sept 2026 (T+90)
1,797 sharesCommon StockSEC:0001780030-26-000004:0
Canonical exit: 20 Sept 2026 (T+90)
1,118 sharesCommon StockSEC:0001780030-26-000004:1
Canonical exit: 20 Sept 2026 (T+90)
1,583 sharesCommon StockSEC:0001780030-26-000004:2
Canonical exit: 20 Sept 2026 (T+90)
3,329 sharesCommon StockSEC:0001780030-26-000004:3
Canonical exit: 20 Sept 2026 (T+90)
356 sharesCommon StockSEC:0001780030-26-000004:4
Canonical exit: 20 Sept 2026 (T+90)
6,836 sharesCommon StockSEC:0001780030-26-000004:5
Canonical exit: 21 Sept 2026 (T+90)
1,969 sharesCommon StockSEC:0001780030-26-000004:6
Canonical exit: 21 Sept 2026 (T+90)
425 sharesCommon StockSEC:0001780030-26-000004:7
Canonical exit: 21 Sept 2026 (T+90)
8,500 shares@ US$17.003.0% of flowCommon StockSEC:0000950170-25-029262:0
25,798 sharesCommon StockSEC:0000950170-25-023630:0
68,000 shares@ US$17.0023.8% of flowCommon StockSEC:0000950170-25-011242:0
4,156 shares@ US$22.41021.9% of flowCommon StockSEC:0000950170-24-129452:0
25,799 sharesCommon StockSEC:0000950170-24-128888:0
25,797 sharesCommon StockSEC:0000950170-24-099269:0
27,507 sharesCommon StockSEC:0000950170-24-061638:0
44,996 sharesCommon StockSEC:0000950170-24-017895:0
44,996 sharesCommon StockSEC:0001209191-23-056015:0
25 of 40 declarations
About Stephenson Brian C
STEPHENSON BRIAN C is a declarant, with 40 filings in total. Across the sampled recent filings, covering the period from 2021-05-18 to 2026-06-26, the total reported volume is EUR 3412435 on the sell side and EUR 0 on the buy side, with modal transaction nature Levée d'options. He is listed at BridgeBio Pharma, Inc. as CFO and Treasurer, and at Faeth Therapeutics, Inc. as Chief Financial Officer.
